4
Changes in Ownership
IDEAYA Biosciences, Inc. Filed Acc 0001567619-21-014178
SVP, Chief Scientific Officer sold 10,000 shares at $25.15 ($251,460)
- SVP, Chief Scientific Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dillon Michael P. SVP, Chief Scientific Officer | 2021-07-27 | Option exercise | +5,000 | $6.92 | $34,600 | 103,789 | D: show line 1 in the form |
| Dillon Michael P. SVP, Chief Scientific Officer | 2021-07-27 | Option exercise | +5,000 | $4.31 | $21,550 | 108,789 | D: show line 2 in the form |
| Dillon Michael P. SVP, Chief Scientific Officer | 2021-07-27 | Sale | −10,000 | $25.15 | $251,460 | 98,789 | D: show line 3 in the form |
| Open-market sales · 10,000 sh · avg $25.15 · $251,460 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dillon Michael P. SVP, Chief Scientific Officer | 2021-07-27 | Option exercise · Stock Option (right to buy) | −5,000 | 39,500 | D: show line 4 in the form | ||
| Dillon Michael P. SVP, Chief Scientific Officer | 2021-07-27 | Option exercise · Stock Option (Right to Buy) | −5,000 | 67,735 | D: show line 5 in the form |
Loading xslF345X03/doc1.xml…